Hosted on MSN

Sickle cell disease treatment algorithms make a difference and reduce hospital stays

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an algorithm for treating children with sickle cell disease who present to ...

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or ...
WHYY

Using race to diagnose anemia in pregnancy led to poor birth outcomes for Black patients, study shows

For years, national medical guidelines have defined anemia differently for patients who are Black. Notably, over the years researchers and clinicians have observed significantly lower levels of iron ...
The American Journal of Managed Care

Impact of Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care

Inflammatory bowel disease (IBD) is commonly associated with iron deficiency anemia (IDA), with a multifactorial pathophysiology. Diagnosis of both IDA and IBD places patients at risk for poor quality ...
WTOP News

Anemia: Signs, Treatment and Prevention

Anemia affects almost 1 in 4 people worldwide. But while billions of people live with the disease, its signs and symptoms aren’t just part of everyday life. “Anemia is one of the most common global ...
Mena FN

Aplastic Anemia Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Prevalence, Therapies, Companies By Delveinsight

"Aplastic Anemia Treatment Market"Aplastic Anemia companies are Pfizer, BioLineRx, Ltd., Regeneron Pharmaceuticals, Gamida Cell, Elixirgen, Hangzhou Zede ...
Healthline

What’s the Difference Between Anemia and Hemolytic Anemia?

Anemia and hemolytic anemia are both conditions that result in too few red blood cells (RBCs). Their causes are different, but both have similar symptoms and can lead to long-term complications. Share ...
Mena FN

Aplastic Anemia Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Prevalence, Therapies, Clinical Trials And Companies By Delveinsight

"Aplastic Anemia Treatment Market"Aplastic Anemia companies are Pfizer, BioLineRx, Ltd., Regeneron Pharmaceuticals, Gamida Cell, Elixirgen, Hangzhou Zede ...